Gutwerg Ori 4

What Happened

• Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals (ANIP), was granted 12,969 restricted shares on 2026-02-26 valued at $77.15/share (total ~$1,000,558).
• On 2026-02-28, 2,221 shares were withheld/disposed at $73.90/share to satisfy tax withholding obligations (proceeds/value ~$164,132). These withholding shares are not an open-market sale of retained shares but a tax-related disposition.

Key Details

• Transaction dates & prices:
  • 2026-02-26: Award of 12,969 RSUs at $77.15 each (A) — $1,000,558 total.
  • 2026-02-28: Shares withheld 2,221 at $73.90 each for taxes (F) — ~$164,132.
• Vesting: The restricted stock award vests in four equal annual installments beginning Feb 26, 2026 (footnote F1).
• Withholding note: The shares withheld for taxes are reported as exempt under Rule 16(b)-3 in connection with the vesting of previously reported restricted shares (footnote F2).
• Shares owned after transaction: not specified in the provided filing.
• Timeliness: Filing dated 2026-03-02 for transactions through 2026-02-26 — no late filing flag indicated.

Context

• This was a compensatory restricted stock grant (not an open-market purchase) and vests over four years; such awards are routine executive compensation. The withholding of shares to cover taxes is a common administrative step and does not necessarily indicate a voluntary sale or change in insider sentiment.